Immunization

The flu vaccine prevented 7.1 million illnesses, according to the analysis, along with 109,000 hospitalizations, and 8000 deaths, during the 2017-2018 influenza season.

Amid a global measles outbreak, some teenagers are questioning their anti-vaxxer parents about not vaccinating them against many dangerous and deadly diseases.

Throughout the country, 47 states and Puerto Rico experienced this in the week ended February 2.

Zoster vaccine recombinant, adjuvanted (Shingrix, GlaxoSmithKline) was approved in October 2017 for the prevention of the viral infection in adults 50 and older.

At least 79 individual cases of measles in the United States have been reported since the start of 2019.

Rite Aid pharmacies are providing measles-mumps-rubella (MMR) vaccinations in 2 states that are seeing an increase in reported measles cases.

Pharmacists Should Carefully Screen for Contraindications and Precautions Before Immunizing Patients.

Overall, 3.1% of people in the United States sought treatment from their health care providers for flu-like illness during the week ended January 12, 2019.

Healthy People 2020 Goals Prove Elusive, but Pharmacists Can Advocate, Educate, Identify, and Immunize.

The most effective interventions in patients are multifaceted, not singly focused.

Measles outbreaks are on the rise globally, and it is considered a public health crisis.

The FDA has approved Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Tdap) use to include repeat vaccination to help protect against tetanus, diphtheria and pertussis.

This vaccine does not constitute a primary immunization series against pertussis.

This is the only vaccination approved in the United States to prevent this bacterial disease.

Influenza vaccinations among patients with diabetes rose by 20% when they were notified about scheduling their flu shot, according to a new study.

A new report published in the CDC Morbidity and Mortality Weekly Report (MMWR) has linked cases of acute hepatitis A virus (HAV) infections from certain states to person-to-person transmission from drug use or homelessness.

Findings showed that LAIV was more effective in those vaccinated in both the enrollment season and the prior season than in those vaccinated only in the enrollment season.

Although HPV vaccination rates have steadily increased in recent years, more work is needed in this area to effectively reduce HPV-associated cancer, according to a new report release by the President’s Cancer Panel.

Flu season has arrived once again, and pharmacists across the country are gearing up to provide patients with vaccines to prevent influenza and medications to treat it.

Officials with the FDA have approved baloxavir marboxil (Xofluza, Shionogi) for the treatment of acute uncomplicated influenza in patients aged 12 years and older who have been symptomatic for no more than 48 hours.

The vaccine, produced by Seqirus, was first approved in the United States in August 2016 for adults 18 and older.

CDC officials note that it is safe to be around infants and young children, pregnant women, or people with weakened immune systems after you get the shingles vaccine.

Ed Cohen, PharmD, who is Executive Vice President of Pharmacy Advocacy for Pharmacy Times, discusses tips for pharmacists who get questions from patients on the shingles vaccine.

Top news of the day from across the health care landscape.

A new review of clinical trial data show the combination therapy elbasvir/grazoprevir (EBR/GR) has high rates of efficacy for patients with genotypes 1a, 1b, and 4 chronic hepatitis C (HCV) infection.

Brown-bag consults can be essential educational and safety tools to measure and ensure quality care. By asking patients to bring in all their current medications, including OTC, mail-order, specialty, and herbal products, pharmacists can guarantee appropriate and up-to-date care.

We all dread the signs every flu season: runny nose, sore throat, muscle aches, and fever.

What should these pharmacists do?

Inconsistency of insurance policy coverage, unaffordability, and difficulty accessing vaccine providers were found to be key barriers for adult immunization.

What's the best advice for a patient who is interested in a vaccine against shingles?